Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Physical Therapy (USPH) Total Liabilities (2016 - 2025)

U S Physical Therapy's Total Liabilities history spans 12 years, with the latest figure at $342.0 million for Q3 2023.

  • For Q3 2023, Total Liabilities rose 2.71% year-over-year to $342.0 million; the TTM value through Sep 2023 reached $342.0 million, up 2.71%, while the annual FY2022 figure was $373.6 million, 25.79% up from the prior year.
  • Total Liabilities for Q3 2023 was $342.0 million at U S Physical Therapy, down from $344.1 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $384.4 million in Q1 2023 and bottomed at $164.7 million in Q1 2019.
  • The 5-year median for Total Liabilities is $201.3 million (2021), against an average of $254.0 million.
  • The largest annual shift saw Total Liabilities skyrocketed 96.42% in 2019 before it plummeted 30.03% in 2021.
  • A 5-year view of Total Liabilities shows it stood at $181.4 million in 2019, then increased by 1.65% to $184.4 million in 2020, then soared by 61.06% to $297.0 million in 2021, then grew by 25.79% to $373.6 million in 2022, then fell by 8.46% to $342.0 million in 2023.
  • Per Business Quant, the three most recent readings for USPH's Total Liabilities are $342.0 million (Q3 2023), $344.1 million (Q2 2023), and $384.4 million (Q1 2023).